Smallcap Sweep. 03-Jul-23
Meat-free news substitute
MTI Wireless Edge (MWE) repeat order from a European customer, worth US$1.4m. Delivery within 14 months. [SP=44.82 Cap=39m]
Sondrel (SND) completes second key milestone in a material turnkey ASIC contract for a Tier 1 OEM Automotive customer. [SP=64 Cap=56m]
Avon Protection (AVON) gets second delivery order worth $38m from the U.S. Army under the Next Generation Integrated Head Protection System contract. [SP=852 Cap=256m]
Gresham Technologies (GHT) $240k PA five yr contract for Clareti. [SP=140 Cap=117m]
Eagle Eye Solutions (EYE) 5 yr contract with Morrisons for loyalty and promotion services. No £££. [SP=510.75 Cap=151m]
Verici Dx (VRCI) validation of Clarava (pre-transplant prognostic test for risk of early kidney rejection) from an international clinical study. Co on track to commence the initial US commercial launch of Clarava before the end of 2023. [SP=12 Cap=20m]
Eden Research (EDEN) Ecovelex seed treatment approved in UK. [SP=9.41 Cap=36m]
Blancco Technology (BLTG) guides FY-June revabove market expectations and op profit comfortably higher. [SP=157 Cap=118m]
Science in Sport (SIS) one of several shares suspended since FY accounts late. [SP=12.5 Cap=22m]
ITM Power (ITM) strategic (natch') collaboration with Mott Corporation to further advance porous transport layers in electrolyser stacks. [SP=72.58 Cap=447m]
Supply@ME (SYME) first UK Inventory Monetisation transaction using traditional funding sources. 3 yr £1.8m max. [SP=0.12 Cap=78m]
Me Group (MEGP) buys Japanese photobooth biz fot £5.5m. Biz made £0.29m pretax av. Projects biz will add £2.2m pretax in FY24. That's an aggressive improvement. [SP=163.57 Cap=619m]
MGC Pharmaceuticals (MXC) Australia becomes the first country to allow psychiatrists to prescribe psychedelics to patients with depression or post-traumatic stress disorder. "MGC has positioned itself as a key player in pioneering psychedelic research and development and as a result, the Company is now able to offer accurate, pharmaceutical-grade products. " [SP=NA Cap=NA]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Got a credit card? use our Credit Card & Finance Calculators
Thanks to Wasron,jfgw,Rhyd6,eyeball08,Wondergirly, for Donating to support the site
MrC's Smallcap Sweeps for Jul 2023
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 04-Jul-23
No let up in let downs
Restore (RST) warns FY adj pretax only £31m. Blames continued weakness in Technology business, a reduction in demand for certain service lines and weak recycled shredded paper price. [SP=231.72 Cap=317m]
Trakm8 (TRAK) FY-Mar. Outlook - warns H1 rev flat due to reinsurance cost and capacity issues but FY "to continue trend of improved performance with strong second half revenues, including from a significant software contract". [SP=14.9 Cap=7m]
Kooth (KOO) $188m four year contract in California. Hikes FY23 rev guidance to £34m but significant upfront costs in respect of the contract. Increased EBITDA margin in FY24, and thereafter. £10m placing at 300p, a 15% premium. [SP=261 Cap=86m]
Hydrogen Utopia (HUI) EU grant for 75% of expenditure of up to €450k in identifying a solution for creating value from such plastic waste through processing it into syngas and hydrogen. [SP=7.5 Cap=29m]
Science in Sport (SIS) unsuspended on publication of AR. [SP=12.5 Cap=22m]
Aptamer (APTA) guides FY-June rev in line. FY24 pipeline (not orders) for fee-for-service rev £2.2m. To cut op C/F to -£3m and plans to reach positive cash flow by the end of FY26, which will require approximately £6m rev by then. "In addition to trading income in July, further funding will be required in the short term in order to continue as a going concern." [SP=6.51 Cap=4m]
Guild Esport (GILD) enters British F4 Esports Championship, its first in competitive simulated racing. [SP=0.62 Cap=4m]
Versarien (VRS) GM stmt with op update. Cost base has been reduced significantly. [SP=1.9 Cap=5m]
Insig AI (INSG) extends Richard Bernstein convert by six months to 30 Dec. [SP=15 Cap=15m]
Coral Products (CRU) following better than expected results at Alma Products, with rev in the earn out period of £9.6m and an adj EBITDA of £0.6m, earn-out consideration will be £1.275m. Also unused property sold for £225k. [SP=14.65 Cap=13m]
Synectics (SNX) c.£2m contract to supply specialist camera stations for Saudi Aramco's Zuluf development programme. A significant proportion to be delivered in FY-Nov. [SP=106.24 Cap=19m]
In line: KETL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
No let up in let downs
Restore (RST) warns FY adj pretax only £31m. Blames continued weakness in Technology business, a reduction in demand for certain service lines and weak recycled shredded paper price. [SP=231.72 Cap=317m]
Trakm8 (TRAK) FY-Mar. Outlook - warns H1 rev flat due to reinsurance cost and capacity issues but FY "to continue trend of improved performance with strong second half revenues, including from a significant software contract". [SP=14.9 Cap=7m]
Kooth (KOO) $188m four year contract in California. Hikes FY23 rev guidance to £34m but significant upfront costs in respect of the contract. Increased EBITDA margin in FY24, and thereafter. £10m placing at 300p, a 15% premium. [SP=261 Cap=86m]
Hydrogen Utopia (HUI) EU grant for 75% of expenditure of up to €450k in identifying a solution for creating value from such plastic waste through processing it into syngas and hydrogen. [SP=7.5 Cap=29m]
Science in Sport (SIS) unsuspended on publication of AR. [SP=12.5 Cap=22m]
Aptamer (APTA) guides FY-June rev in line. FY24 pipeline (not orders) for fee-for-service rev £2.2m. To cut op C/F to -£3m and plans to reach positive cash flow by the end of FY26, which will require approximately £6m rev by then. "In addition to trading income in July, further funding will be required in the short term in order to continue as a going concern." [SP=6.51 Cap=4m]
Guild Esport (GILD) enters British F4 Esports Championship, its first in competitive simulated racing. [SP=0.62 Cap=4m]
Versarien (VRS) GM stmt with op update. Cost base has been reduced significantly. [SP=1.9 Cap=5m]
Insig AI (INSG) extends Richard Bernstein convert by six months to 30 Dec. [SP=15 Cap=15m]
Coral Products (CRU) following better than expected results at Alma Products, with rev in the earn out period of £9.6m and an adj EBITDA of £0.6m, earn-out consideration will be £1.275m. Also unused property sold for £225k. [SP=14.65 Cap=13m]
Synectics (SNX) c.£2m contract to supply specialist camera stations for Saudi Aramco's Zuluf development programme. A significant proportion to be delivered in FY-Nov. [SP=106.24 Cap=19m]
In line: KETL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 05-Jul-23
Supreme smoking, Quiz choking.
Supreme (SUP) FY-Mar. Guides FY24 significantly ahead of current consensus of £159m rev and adj EBITDA £22.6m. Becomes master distributor for the UK's leading vaping brands, ElfBar and Lost Mary. Guides extra £25 -30m rev and c. £2m adj EBITDA in FY24. [SP=104.5 Cap=123m]
Equals (EQLS) guiides H1-June rev up 43% and gross profit margins over 50% (47%). Guides FY at least in line. Completes acquisition of Oonex. [SP=96 Cap=175m]
Tintra (TNT) will pay 3m in full repayment and termination of the Placement Facility (announced Dec) with Fintech Leaders Fund. [SP=93.3 Cap=15m]
Mattioli Woods (MTW) guides FY-May rev up 3% and adj pretax in line with £30m f/c. Outlook - "Recent new business development and marketing initiatives, designed to assist clients in understanding the recent changes to pension and tax rules, such as movements in annual and lifetime allowances, have both generated increased levels of new business and resulted in a strong increase of +16% in new business enquiries versus the prior year." [SP=620 Cap=320m]
Bidstack (BIDS) GM requisition to remove Glen Calvert and Lisa Hau as directors and appoint Nicholas Hargrave. [SP=0.9 Cap=12m]
Arecor Therapeutics (AREC) addition agreement with a leading biopharmaceutical company to support the ongoing development of a biosimilar product. [SP=240 Cap=70m]
Zinc Media (ZIN) rev end June won and due to be recognised in FY23 is £31m, more than all FY22. [SP=86.9 Cap=19m]
Numis (NUM) Q3 total rev below H1 half run-rate "reflecting a deteriorating market backdrop across the investment banking industry". Expects difficult market conditions for erst of FY23. Acquisition by Deutsche Bank AG expected to complete during Q3 calendar 2023. [SP=332.75 Cap=366m]
Graft Polymer (GPL) completion and commissioning of a production equipment site in Slovenia (due around the end of July), doubling production capacity. [SP=2.7 Cap=3m]
PayPoint (PAY) FY23 prelims due tomorrow are delayed "due to a technical accounting treatment relating to the balance sheet of the Appreciate at acquisition". Confirms rev in line and pretax at the top end of market expectations, excluding exceptional items and Appreciate impacts. Current trading positive. [SP=467 Cap=339m]
AO World (AO.) FY-Mar rev in line. Outlook - "confident in our ability to deliver on our 5% EBITDA ambition in the short term and returning to top line growth in the medium term". [SP=80.25 Cap=463m]
Redde Northgate (REDD) FY-Apr. Outlook - "continue to enjoy robust demand as we start FY2024 and our recent signing of a further multi-service outsourcing contract for Redde reflects our healthy new business pipeline". [SP=378.22 Cap=867m]
Quiz (QUIZ) FY-Mar rev in line. Outlook - Q1 rev down 15% "reflecting the strong prior year comparatives in the first half as well as the impact of the macroeconomic uncertainty and inflationary pressures". Guides FY24 pretax flat as H2 trading environment is expected to remain challenging, [SP=11 Cap=14m]
In line: ETP, TPT, SMV
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Supreme smoking, Quiz choking.
Supreme (SUP) FY-Mar. Guides FY24 significantly ahead of current consensus of £159m rev and adj EBITDA £22.6m. Becomes master distributor for the UK's leading vaping brands, ElfBar and Lost Mary. Guides extra £25 -30m rev and c. £2m adj EBITDA in FY24. [SP=104.5 Cap=123m]
Equals (EQLS) guiides H1-June rev up 43% and gross profit margins over 50% (47%). Guides FY at least in line. Completes acquisition of Oonex. [SP=96 Cap=175m]
Tintra (TNT) will pay 3m in full repayment and termination of the Placement Facility (announced Dec) with Fintech Leaders Fund. [SP=93.3 Cap=15m]
Mattioli Woods (MTW) guides FY-May rev up 3% and adj pretax in line with £30m f/c. Outlook - "Recent new business development and marketing initiatives, designed to assist clients in understanding the recent changes to pension and tax rules, such as movements in annual and lifetime allowances, have both generated increased levels of new business and resulted in a strong increase of +16% in new business enquiries versus the prior year." [SP=620 Cap=320m]
Bidstack (BIDS) GM requisition to remove Glen Calvert and Lisa Hau as directors and appoint Nicholas Hargrave. [SP=0.9 Cap=12m]
Arecor Therapeutics (AREC) addition agreement with a leading biopharmaceutical company to support the ongoing development of a biosimilar product. [SP=240 Cap=70m]
Zinc Media (ZIN) rev end June won and due to be recognised in FY23 is £31m, more than all FY22. [SP=86.9 Cap=19m]
Numis (NUM) Q3 total rev below H1 half run-rate "reflecting a deteriorating market backdrop across the investment banking industry". Expects difficult market conditions for erst of FY23. Acquisition by Deutsche Bank AG expected to complete during Q3 calendar 2023. [SP=332.75 Cap=366m]
Graft Polymer (GPL) completion and commissioning of a production equipment site in Slovenia (due around the end of July), doubling production capacity. [SP=2.7 Cap=3m]
PayPoint (PAY) FY23 prelims due tomorrow are delayed "due to a technical accounting treatment relating to the balance sheet of the Appreciate at acquisition". Confirms rev in line and pretax at the top end of market expectations, excluding exceptional items and Appreciate impacts. Current trading positive. [SP=467 Cap=339m]
AO World (AO.) FY-Mar rev in line. Outlook - "confident in our ability to deliver on our 5% EBITDA ambition in the short term and returning to top line growth in the medium term". [SP=80.25 Cap=463m]
Redde Northgate (REDD) FY-Apr. Outlook - "continue to enjoy robust demand as we start FY2024 and our recent signing of a further multi-service outsourcing contract for Redde reflects our healthy new business pipeline". [SP=378.22 Cap=867m]
Quiz (QUIZ) FY-Mar rev in line. Outlook - Q1 rev down 15% "reflecting the strong prior year comparatives in the first half as well as the impact of the macroeconomic uncertainty and inflationary pressures". Guides FY24 pretax flat as H2 trading environment is expected to remain challenging, [SP=11 Cap=14m]
In line: ETP, TPT, SMV
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 06-Jul-23
Arguing the toss over quality and dross
CyanConnode (CYAN) guides FY-Mar rev broadly in line with market expectations but no figure. Three months guys! Guides adj EBITDA miss due to higher proportion of revenue from Middle East, on lower margin hardware. [SP=13.92 Cap=38m]
TClarke (CTO) £10.7m placing at 122p, a 14% discount, for working cap. Trading still strong and highly confident that FY rev will be over £500m. [SP=142.5 Cap=63m]
Gelion (GELN) update on its battery tech. [SP=26.99 Cap=29m]
Deltex Medical (DEMG) guides H1-June rev £1.1m, down £100k. Waiting for an ambulance agan with only £100k cash at hand. Considering another fundraise. [SP=1.1 Cap=9m]
Distil (DIS) Q1 rev up 206% "lapping a suppressed Q1 in 2022 as a result of remodelling the business". [SP=0.31 Cap=2m]
Abingdon Health (ABDX) guides FY-June rev up 42% and 125% higher ex covid revs. Cash at hand £3.2m, in line. [SP=12.15 Cap=15m]
Robert Walters (RWA) Q2-June net fee income down 10%. "As reported in our June trading update, candidate confidence and time to hire are not yet showing the anticipated signs of sustained improvement." [SP=422.06 Cap=313m]
Byotrol (BYOT) gets UK patent for anti-viral properties of certain enhanced extracts of commonly available brown seaweed. [SP=1.81 Cap=9m]
Sabien Technology (SNT) FY-June trading. M2G rev up 62%. No rev fig for b.grn. [SP=12.49 Cap=3m]
In line: PEEL, NFG, TPX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Arguing the toss over quality and dross
CyanConnode (CYAN) guides FY-Mar rev broadly in line with market expectations but no figure. Three months guys! Guides adj EBITDA miss due to higher proportion of revenue from Middle East, on lower margin hardware. [SP=13.92 Cap=38m]
TClarke (CTO) £10.7m placing at 122p, a 14% discount, for working cap. Trading still strong and highly confident that FY rev will be over £500m. [SP=142.5 Cap=63m]
Gelion (GELN) update on its battery tech. [SP=26.99 Cap=29m]
Deltex Medical (DEMG) guides H1-June rev £1.1m, down £100k. Waiting for an ambulance agan with only £100k cash at hand. Considering another fundraise. [SP=1.1 Cap=9m]
Distil (DIS) Q1 rev up 206% "lapping a suppressed Q1 in 2022 as a result of remodelling the business". [SP=0.31 Cap=2m]
Abingdon Health (ABDX) guides FY-June rev up 42% and 125% higher ex covid revs. Cash at hand £3.2m, in line. [SP=12.15 Cap=15m]
Robert Walters (RWA) Q2-June net fee income down 10%. "As reported in our June trading update, candidate confidence and time to hire are not yet showing the anticipated signs of sustained improvement." [SP=422.06 Cap=313m]
Byotrol (BYOT) gets UK patent for anti-viral properties of certain enhanced extracts of commonly available brown seaweed. [SP=1.81 Cap=9m]
Sabien Technology (SNT) FY-June trading. M2G rev up 62%. No rev fig for b.grn. [SP=12.49 Cap=3m]
In line: PEEL, NFG, TPX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 07-Jul-23
Are you being swerved?
Creightons (CRL) FY-Mar rev down 4%. Pretax down 80%. There was no trading stmt since H2 in Dec. Biz returned to to profitability and positive cashflow in H2. No current trading. [SP=31.1 Cap=21m]
MGC Pharmaceuticals (MXC) another $1m from AMC Pharma for ArtemiC. [SP=0.23 Cap=8m]
Quadrise (QED) £1m placing and £2.25m OO at 1.25p, a 34% discount, to keep the lights on. [SP=1.71 Cap=24m]
Aptamer (APTA) £507k contract wins, included in the pipeline set out in recent RNS. Still needs further funding in the short-term. [SP=4.47 Cap=3m]
Capital (CAPD) positive operational and financial developments in majority-owned co MSALABS. Also $10m placing means CAPD's holding up from 77.8% to 81.8%. [SP=93.8 Cap=181m]
In line: SPA
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Are you being swerved?
Creightons (CRL) FY-Mar rev down 4%. Pretax down 80%. There was no trading stmt since H2 in Dec. Biz returned to to profitability and positive cashflow in H2. No current trading. [SP=31.1 Cap=21m]
MGC Pharmaceuticals (MXC) another $1m from AMC Pharma for ArtemiC. [SP=0.23 Cap=8m]
Quadrise (QED) £1m placing and £2.25m OO at 1.25p, a 34% discount, to keep the lights on. [SP=1.71 Cap=24m]
Aptamer (APTA) £507k contract wins, included in the pipeline set out in recent RNS. Still needs further funding in the short-term. [SP=4.47 Cap=3m]
Capital (CAPD) positive operational and financial developments in majority-owned co MSALABS. Also $10m placing means CAPD's holding up from 77.8% to 81.8%. [SP=93.8 Cap=181m]
In line: SPA
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 10-Jul-23
First service
Deltex Medical (DEMG) UK and EU launch of its new next generation TrueVue System. Will spend 3 months testing in hopsotals before co takes orders. [SP=1.1 Cap=9m]
Hemogenyx Pharmaceuticals (HEMO) FDA puts product candidate Chimeric Antigen Receptor T-cells for the treatment of acute myeloid leukaemia on clinical hold. Cites manufacturing process problem to which HEMO has a fix. [SP=1.42 Cap=17m]
RM Infrastructure Income (RMII) consultation concludes that co will not offer a partial exit opportunity because the co is already sub-scale. "Progress concerning a potential combination of the Company's assets with another suitable investment company or fund remains limited." Will ut forward proposals on future of co ASAP. [SP=67.5 Cap=80m]
WANdisco (WAND) Tesco renews support and maintenance contract. $200k over 2 yrs. [SP=1310 Cap=9m]
Tissue Regenix (TRX) 3 yr UK distribution agreement for OrthoPure XT, "the only available, non-human biologic graft for certain anterior cruciate ligament ('ACL') reconstruction procedures". [SP=50.02 Cap=36m]
Ondo InsurTech (ONDO) Sweden's largest non-life insurer - sign new five-year contract to support LeakBot's rollout across the group. Opportunity is worth over £30m. [SP=18.65 Cap=14m]
ITM Power (ITM) will open office and warehouse in Germany in Oct. [SP=67.56 Cap=416m]
Impax Asset Management (IPX) AuM up 2.2% in June but down 1% in Q. [SP=529.63 Cap=702m]
Scancell (SCLP) drug update. Co to focus on development of Company's two lead clinical assets SCIB1 and Modi-1. [SP=12.9 Cap=107m]
Non-Standard Finance (NSF) assets disposed, nil for holders. Will de-list on Aug 8. [SP=0.05 Cap=m]
In line: QTX, AGFX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
First service
Deltex Medical (DEMG) UK and EU launch of its new next generation TrueVue System. Will spend 3 months testing in hopsotals before co takes orders. [SP=1.1 Cap=9m]
Hemogenyx Pharmaceuticals (HEMO) FDA puts product candidate Chimeric Antigen Receptor T-cells for the treatment of acute myeloid leukaemia on clinical hold. Cites manufacturing process problem to which HEMO has a fix. [SP=1.42 Cap=17m]
RM Infrastructure Income (RMII) consultation concludes that co will not offer a partial exit opportunity because the co is already sub-scale. "Progress concerning a potential combination of the Company's assets with another suitable investment company or fund remains limited." Will ut forward proposals on future of co ASAP. [SP=67.5 Cap=80m]
WANdisco (WAND) Tesco renews support and maintenance contract. $200k over 2 yrs. [SP=1310 Cap=9m]
Tissue Regenix (TRX) 3 yr UK distribution agreement for OrthoPure XT, "the only available, non-human biologic graft for certain anterior cruciate ligament ('ACL') reconstruction procedures". [SP=50.02 Cap=36m]
Ondo InsurTech (ONDO) Sweden's largest non-life insurer - sign new five-year contract to support LeakBot's rollout across the group. Opportunity is worth over £30m. [SP=18.65 Cap=14m]
ITM Power (ITM) will open office and warehouse in Germany in Oct. [SP=67.56 Cap=416m]
Impax Asset Management (IPX) AuM up 2.2% in June but down 1% in Q. [SP=529.63 Cap=702m]
Scancell (SCLP) drug update. Co to focus on development of Company's two lead clinical assets SCIB1 and Modi-1. [SP=12.9 Cap=107m]
Non-Standard Finance (NSF) assets disposed, nil for holders. Will de-list on Aug 8. [SP=0.05 Cap=m]
In line: QTX, AGFX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 11-Jul-23
Heavy winners
STM (STM) 70p possible offer. a 155% premium. [SP=27.9 Cap=16m]
Eagle Eye Solutions (EYE) guides FY-June rev up 36% and adj EBITDA up 32%, ahead of Board expectations. [SP=546.53 Cap=160m]
MyCelx Technologies (MYX) contract extension for wastewater treatment in Middle East. Helps underpin market forecast. [SP=35.85 Cap=8m]
Riverstone Energy (RSE) portfolio co Anuvia goes bust - $14m writedown. [SP=544 Cap=254m]
Cornerstone FS (CSFS) Q2 continued strongly so guides H1 rev up 89% and a maiden positive adjusted EBITDA. [SP=10.15 Cap=6m]
Forterra (FORT) guides H1-June rev c.£183m and adj pretax c.£18m, broadly in line with mgmt expectations. Market improvement less pronounced than expected. Guides "only a modest improvement in trading conditions in H2". [SP=163.4 Cap=345m]
Galliford Try (GFRD) guides FY-Sept adj pretax at the upper end of forecasts (£22.1m to £23.3m). [SP=198 Cap=207m]
Ondo InsurTech (ONDO) agrees restructuring of 5-year loan notes with its largest shareholder, Homeserve Assistance. This "supports our accelerated drive to profitability". [SP=21.69 Cap=16m]
H&T (HAT) mixed H1-June trading. "As expected, the exceptional level of redemptions experienced in late April and early May did not continue." In Q2 co prioritised stock turnover ahead of margin but margins are expected to improve in H2. Scrap volumes were particularly strong. [SP=421.26 Cap=186m]
Norman Broadbent (NBB) guides H1-June net fee income up 57% though Q2 was up only 50%. Guides EBITDA over £250k. CEO delighted with progress. [SP=5.5 Cap=3m]
WANdisco (WAND) wins contract worth $7,680 with FordDirect. "Though small in initial value, this is the first contract the Company has signed with FordDirect." [SP=1310 Cap=9m]
In line: TRT, MPAC, EMIS, SOS, BEG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Heavy winners
STM (STM) 70p possible offer. a 155% premium. [SP=27.9 Cap=16m]
Eagle Eye Solutions (EYE) guides FY-June rev up 36% and adj EBITDA up 32%, ahead of Board expectations. [SP=546.53 Cap=160m]
MyCelx Technologies (MYX) contract extension for wastewater treatment in Middle East. Helps underpin market forecast. [SP=35.85 Cap=8m]
Riverstone Energy (RSE) portfolio co Anuvia goes bust - $14m writedown. [SP=544 Cap=254m]
Cornerstone FS (CSFS) Q2 continued strongly so guides H1 rev up 89% and a maiden positive adjusted EBITDA. [SP=10.15 Cap=6m]
Forterra (FORT) guides H1-June rev c.£183m and adj pretax c.£18m, broadly in line with mgmt expectations. Market improvement less pronounced than expected. Guides "only a modest improvement in trading conditions in H2". [SP=163.4 Cap=345m]
Galliford Try (GFRD) guides FY-Sept adj pretax at the upper end of forecasts (£22.1m to £23.3m). [SP=198 Cap=207m]
Ondo InsurTech (ONDO) agrees restructuring of 5-year loan notes with its largest shareholder, Homeserve Assistance. This "supports our accelerated drive to profitability". [SP=21.69 Cap=16m]
H&T (HAT) mixed H1-June trading. "As expected, the exceptional level of redemptions experienced in late April and early May did not continue." In Q2 co prioritised stock turnover ahead of margin but margins are expected to improve in H2. Scrap volumes were particularly strong. [SP=421.26 Cap=186m]
Norman Broadbent (NBB) guides H1-June net fee income up 57% though Q2 was up only 50%. Guides EBITDA over £250k. CEO delighted with progress. [SP=5.5 Cap=3m]
WANdisco (WAND) wins contract worth $7,680 with FordDirect. "Though small in initial value, this is the first contract the Company has signed with FordDirect." [SP=1310 Cap=9m]
In line: TRT, MPAC, EMIS, SOS, BEG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 12-Jul-23
Sliced returns
Argo Blockchain (ARB) Bitcoins mined in June down 17% on May. Blames higher average network difficulty and increased curtailment of mining operations at the Helios facility". New kit in Quebec expected to increase hashrate capacity by 12%. [SP=12.5 Cap=73m]
Fiinu (BANK) cost cuts and redundancies at subsidiaries, Fiinu 2 Limited and Fiinu Holdings as co fails to get exit funding to consider seeking re-application of banking license. Also "unable to utilise the funding options announced on 15 March 2023 with Dewscope Limited and GEM Global Yield and GEM Yield Bahamas". £4.3m at hand. Options include a change of strategy and/or a sale of the Group's technology assets. [SP=6.3 Cap=17m]
RBG Holdings (RBGP) gets £1 for LionFish plus £1.1m loan repaid and an additional payment of up to £2m, subject to performance conditions, to repay additional intercompany debt. Book loss of £1m (assuming all £2m repaid?). [SP=28 Cap=27m]
Kelso (KLSO) has made £1.7m on THG shares purchases. [SP=2.65 Cap=8m]
XLMedia (XLM) sells three European gaming domains and associated websites for $4m = 4.7x rev. Co will continue to operate igaming business in the Swedish and other European markets. [SP=10 Cap=26m]
Shoe Zone (SHOE) guides FY-Oct adj pretax £13.5m+ after an exceptional month of sales. "Volumes up double digit on last year, despite no price increases on our core ranges." Surely no price rises helps volume! Margins better due to the lower container rates and favourable FX. [SP=238.55 Cap=110m]
In line: ITX, HSW
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Sliced returns
Argo Blockchain (ARB) Bitcoins mined in June down 17% on May. Blames higher average network difficulty and increased curtailment of mining operations at the Helios facility". New kit in Quebec expected to increase hashrate capacity by 12%. [SP=12.5 Cap=73m]
Fiinu (BANK) cost cuts and redundancies at subsidiaries, Fiinu 2 Limited and Fiinu Holdings as co fails to get exit funding to consider seeking re-application of banking license. Also "unable to utilise the funding options announced on 15 March 2023 with Dewscope Limited and GEM Global Yield and GEM Yield Bahamas". £4.3m at hand. Options include a change of strategy and/or a sale of the Group's technology assets. [SP=6.3 Cap=17m]
RBG Holdings (RBGP) gets £1 for LionFish plus £1.1m loan repaid and an additional payment of up to £2m, subject to performance conditions, to repay additional intercompany debt. Book loss of £1m (assuming all £2m repaid?). [SP=28 Cap=27m]
Kelso (KLSO) has made £1.7m on THG shares purchases. [SP=2.65 Cap=8m]
XLMedia (XLM) sells three European gaming domains and associated websites for $4m = 4.7x rev. Co will continue to operate igaming business in the Swedish and other European markets. [SP=10 Cap=26m]
Shoe Zone (SHOE) guides FY-Oct adj pretax £13.5m+ after an exceptional month of sales. "Volumes up double digit on last year, despite no price increases on our core ranges." Surely no price rises helps volume! Margins better due to the lower container rates and favourable FX. [SP=238.55 Cap=110m]
In line: ITX, HSW
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 13-Jul-23
A volley of news
Arix Bioscience (ARIX) strategic review to include investment and realisation strategies, capital allocation and shareholder returns policies, and a tax-efficient wind-down. [SP=97.56 Cap=126m]
Trustpilot (TRST) guides H1 rev up 15%. Expects FY adj EBITDA above the top end of the range of market expectations of $2.4-4m with rev in line. [SP=66.97 Cap=280m]
Avingtrans (AVG) guides FY-May in line with market expectations. New orders. Offers £3m in paper for the remaining shares in Adaptix, the emerging MedTech business. Accepted by the majority of Adaptix shareholders. [SP=412 Cap=133m]
Novacyt (NCYT) AGM due on 10 Aug cancelled and will be held by the end of October. Cites delayed FY accounts and offer for Yourgene Health. [SP=43 Cap=37m]
Seraphim Space Investment Trust (SSIT) share buyback programme. Investment activity has been robust. [SP=26.1 Cap=62m]
IQ-AI (IQAI) subsidiary gets FDA Orphan Drug Designation (for gallium maltolate for the treatment of pediatric glioblastoma multiforme) extended to non-adults. [SP=2.55 Cap=5m]
Proton Motor Power Systems (PPS) follow-on order from DB Bahnbau Gruppe. Delivery Q1 2024. No £££. [SP=8 Cap=124m]
Helical (HLCL) AGM trading stmt - 'good progress'. In line? [SP=268 Cap=331m]
In line: HAS, CNS, GYM, APTD
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
A volley of news
Arix Bioscience (ARIX) strategic review to include investment and realisation strategies, capital allocation and shareholder returns policies, and a tax-efficient wind-down. [SP=97.56 Cap=126m]
Trustpilot (TRST) guides H1 rev up 15%. Expects FY adj EBITDA above the top end of the range of market expectations of $2.4-4m with rev in line. [SP=66.97 Cap=280m]
Avingtrans (AVG) guides FY-May in line with market expectations. New orders. Offers £3m in paper for the remaining shares in Adaptix, the emerging MedTech business. Accepted by the majority of Adaptix shareholders. [SP=412 Cap=133m]
Novacyt (NCYT) AGM due on 10 Aug cancelled and will be held by the end of October. Cites delayed FY accounts and offer for Yourgene Health. [SP=43 Cap=37m]
Seraphim Space Investment Trust (SSIT) share buyback programme. Investment activity has been robust. [SP=26.1 Cap=62m]
IQ-AI (IQAI) subsidiary gets FDA Orphan Drug Designation (for gallium maltolate for the treatment of pediatric glioblastoma multiforme) extended to non-adults. [SP=2.55 Cap=5m]
Proton Motor Power Systems (PPS) follow-on order from DB Bahnbau Gruppe. Delivery Q1 2024. No £££. [SP=8 Cap=124m]
Helical (HLCL) AGM trading stmt - 'good progress'. In line? [SP=268 Cap=331m]
In line: HAS, CNS, GYM, APTD
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 14-Jul-23
Double fault
Versarien (VRS) yet another placing to keep the lights on: £650k at 1p, a 44% discount. [SP=1.75 Cap=5m]
MGC Pharmaceuticals (MXC) in a follow-my-bleeder move also makes a £650k placing at 0.12p, a 57% discount, to keep the lights on. Warrants at 0.12p. [SP=0.26 Cap=7m]
ZOO Digital (ZOO) warns Q1 rev below management expectations which was already expected to be weaker YoY due to industry weakness. FY-Mar23 IFRS 15 guidance - adj EBITDA $2m higher. However co expects to inc mkt share due to several customers rationalisation their supplier bases, with ZOO selected as one of a smaller number of vendors. [SP=104.5 Cap=102m]
Galliford Try (GFRD) £72m contract . [SP=205 Cap=214m]
McBride (MCB) guides FY-June adj op profit t the top end of guided range - see Apr RNS. [SP=25.1 Cap=44m]
TheWorks (WRKS) FY results delayed from 21 Jul to 2 Aug. Guides adj EBITDA in line. [SP=33 Cap=21m]
Smoove (SMV) deadline for firm offer pushed back to 11 Aug. [SP=38.44 Cap=22m]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Double fault
Versarien (VRS) yet another placing to keep the lights on: £650k at 1p, a 44% discount. [SP=1.75 Cap=5m]
MGC Pharmaceuticals (MXC) in a follow-my-bleeder move also makes a £650k placing at 0.12p, a 57% discount, to keep the lights on. Warrants at 0.12p. [SP=0.26 Cap=7m]
ZOO Digital (ZOO) warns Q1 rev below management expectations which was already expected to be weaker YoY due to industry weakness. FY-Mar23 IFRS 15 guidance - adj EBITDA $2m higher. However co expects to inc mkt share due to several customers rationalisation their supplier bases, with ZOO selected as one of a smaller number of vendors. [SP=104.5 Cap=102m]
Galliford Try (GFRD) £72m contract . [SP=205 Cap=214m]
McBride (MCB) guides FY-June adj op profit t the top end of guided range - see Apr RNS. [SP=25.1 Cap=44m]
TheWorks (WRKS) FY results delayed from 21 Jul to 2 Aug. Guides adj EBITDA in line. [SP=33 Cap=21m]
Smoove (SMV) deadline for firm offer pushed back to 11 Aug. [SP=38.44 Cap=22m]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 17-Jul-23
Unbound finally trips into sinkhole.
Unbound (UBG) shoe co run by heels suspended as it plans to put main operating subsidiary, Beaconsfield Footwear into administration. [SP=0.74 Cap=m]
Gresham House (GHE) 1105p rec offer, a 63% premium. [SP=671 Cap=257m]
Getech (GTC) wins 3 contracts worth £0.8m over 3 yrs. [SP=9.37 Cap=6m]
East Imperial (EISB) proposed issue of £2.2m 10% converts. Convertible at a 20% discount, but at 1p minimum. [SP=0.81 Cap=3m]
Kanabo (KNB) 40% owned subsidiary, Kanabo Agritec wins contract for for the development of an indoor medical cannabis cultivation and processing facility. No £££ yet. [SP=1.9 Cap=12m]
Guild Esports (GILD) partnership with Pixels AI to generate ad revenues for GILD from its owned video content "by leveraging Pixels'AI-powered video platform". [SP=0.67 Cap=4m]
Advanced Oncotherapy (AVO) still in Formal Sale process talks but alternatively plans a d4e (of £25.7-£37.4m), a £10m loan and a fundraise of up to c.£73m. Loads of warrants natch'. [SP=1.95 Cap=10m]
Cellular Goods (CBX) MoU for a JV to develop carbon sequestration and removal services through sustainable kelp farming. [SP=0.7 Cap=4m]
Dianomi (DMN) warns FY-Dec rev £30.5-32.5m, below mkt exp. H1-June rev was down 18%. Blames even weaker mkt than expected. [SP=NA Cap=NA]
Costain (COST) United Utilities awards 2 yr extension to its Managed Service Provider contract. [SP=47.9 Cap=133m]
Smartspace Software (SMRT) completes sale of freehold asset and the business of Anders + Kern. Gets £1.38m. Got only £0.52m for the biz itself. [SP=37.36 Cap=11m]
DFS (DFS) guides FY-June in line with rev down 4% and adj pretax slightly above £30m. Current trading in line. Guides FY rev down mid-single digits and U/L profit slightly up. Economic outlook remains uncertain. [SP=112 Cap=262m]
IQGeo (IQG) guides H1-June rev up 117%, ahead of prior expectations. Adj EBITDA in line. Order intake up 50%. [SP=301 Cap=185m]
Concurrent Technologies (CNC) guides FY-Dec rev slightly ahead of market expectations and pretax materially ahead. [SP=56.95 Cap=42m]
Oxford Cannabinoid Technologies (OCTP) expanding into oncology after identifying a potential "first in class" immunotherapy agent for the treatment of solid tumours. [SP=0.83 Cap=8m]
Redcentric (RCN) FY delayed due to audit not finished. Reiterates guidance. [SP=129.25 Cap=202m]
UP Global Sourcing (UPGS) guides YE net debt £15m cf £21m expected. [SP=122 Cap=109m]
In line: FSJ, MEX, WNWD, TRX, VINO, OHT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Unbound finally trips into sinkhole.
Unbound (UBG) shoe co run by heels suspended as it plans to put main operating subsidiary, Beaconsfield Footwear into administration. [SP=0.74 Cap=m]
Gresham House (GHE) 1105p rec offer, a 63% premium. [SP=671 Cap=257m]
Getech (GTC) wins 3 contracts worth £0.8m over 3 yrs. [SP=9.37 Cap=6m]
East Imperial (EISB) proposed issue of £2.2m 10% converts. Convertible at a 20% discount, but at 1p minimum. [SP=0.81 Cap=3m]
Kanabo (KNB) 40% owned subsidiary, Kanabo Agritec wins contract for for the development of an indoor medical cannabis cultivation and processing facility. No £££ yet. [SP=1.9 Cap=12m]
Guild Esports (GILD) partnership with Pixels AI to generate ad revenues for GILD from its owned video content "by leveraging Pixels'AI-powered video platform". [SP=0.67 Cap=4m]
Advanced Oncotherapy (AVO) still in Formal Sale process talks but alternatively plans a d4e (of £25.7-£37.4m), a £10m loan and a fundraise of up to c.£73m. Loads of warrants natch'. [SP=1.95 Cap=10m]
Cellular Goods (CBX) MoU for a JV to develop carbon sequestration and removal services through sustainable kelp farming. [SP=0.7 Cap=4m]
Dianomi (DMN) warns FY-Dec rev £30.5-32.5m, below mkt exp. H1-June rev was down 18%. Blames even weaker mkt than expected. [SP=NA Cap=NA]
Costain (COST) United Utilities awards 2 yr extension to its Managed Service Provider contract. [SP=47.9 Cap=133m]
Smartspace Software (SMRT) completes sale of freehold asset and the business of Anders + Kern. Gets £1.38m. Got only £0.52m for the biz itself. [SP=37.36 Cap=11m]
DFS (DFS) guides FY-June in line with rev down 4% and adj pretax slightly above £30m. Current trading in line. Guides FY rev down mid-single digits and U/L profit slightly up. Economic outlook remains uncertain. [SP=112 Cap=262m]
IQGeo (IQG) guides H1-June rev up 117%, ahead of prior expectations. Adj EBITDA in line. Order intake up 50%. [SP=301 Cap=185m]
Concurrent Technologies (CNC) guides FY-Dec rev slightly ahead of market expectations and pretax materially ahead. [SP=56.95 Cap=42m]
Oxford Cannabinoid Technologies (OCTP) expanding into oncology after identifying a potential "first in class" immunotherapy agent for the treatment of solid tumours. [SP=0.83 Cap=8m]
Redcentric (RCN) FY delayed due to audit not finished. Reiterates guidance. [SP=129.25 Cap=202m]
UP Global Sourcing (UPGS) guides YE net debt £15m cf £21m expected. [SP=122 Cap=109m]
In line: FSJ, MEX, WNWD, TRX, VINO, OHT
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 18-Jul-23
Deflating companies with little pricks
Revolution Beauty (REVB) agrees to most of holder boohoo's demands. CEO Bob Holt and Derek Zissman will resign. 4 new dirs. CFO remains. [SP=31.21 Cap=95m]
Litigation Capital Management (LIT) will move to the less conservative Fair Value Accounting, in line with peers. 2.5p div reflect "strong financial performance". [SP=79.8 Cap=95m]
Nanoco (NANO) activist investor Mr Hamoodi requisitions GM to change board. [SP=18.5 Cap=60m]
Carclo (CAR) mooted covenant changes signed. [SP=12.77 Cap=9m]
Osirium Technologies (OSI) guides H1-June rev £1.1+, up 18%, and ARR up 34% to £2.16m. Strong start to H2 but still expects to raise additional capital before the end of the year. [SP=1.5 Cap=2m]
Gulf Marine Services (GMS) interest cost falls 340bps as leverage now below 4:1. [SP=7 Cap=71m]
Luceco (LUCE) guides FY-Dec towards the upper end of market expectations. H1 rev down 5% and adj op profit £10.5m, both ahead of mgmt exp. [SP=117 Cap=188m]
NIOX (NIOX) guides H1-June rev up 22% and adj EBITDA c. £6.2m (£3.2m). Guides FY ahead of mgmt exp. [SP=64.5 Cap=273m]
Pelatro (PTRO) a key customer, owing $550k, will miss agreed payment deadline of July. Review (why does this need a review?) finds 'unusual' delays in payments from 4 customers, tot c.$1.1m. Expects a positive resolution from talks. Cash at hand $0.7m and c.$2.6m coming in by Sept. Exploring financing and funding options in case customers don't pay. [SP=7.68 Cap=4m]
Zotefoams (ZTF) joint development agreement with a world-leading packer for ReZorce beverage cartons. [SP=338 Cap=156m]
IXICO (IXI) $1.7m 4 yr contract. [SP=18.75 Cap=9m]
In line: APH, ART, CPP, BMY, VCAP, JDG, MIRI, DX.
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Deflating companies with little pricks
Revolution Beauty (REVB) agrees to most of holder boohoo's demands. CEO Bob Holt and Derek Zissman will resign. 4 new dirs. CFO remains. [SP=31.21 Cap=95m]
Litigation Capital Management (LIT) will move to the less conservative Fair Value Accounting, in line with peers. 2.5p div reflect "strong financial performance". [SP=79.8 Cap=95m]
Nanoco (NANO) activist investor Mr Hamoodi requisitions GM to change board. [SP=18.5 Cap=60m]
Carclo (CAR) mooted covenant changes signed. [SP=12.77 Cap=9m]
Osirium Technologies (OSI) guides H1-June rev £1.1+, up 18%, and ARR up 34% to £2.16m. Strong start to H2 but still expects to raise additional capital before the end of the year. [SP=1.5 Cap=2m]
Gulf Marine Services (GMS) interest cost falls 340bps as leverage now below 4:1. [SP=7 Cap=71m]
Luceco (LUCE) guides FY-Dec towards the upper end of market expectations. H1 rev down 5% and adj op profit £10.5m, both ahead of mgmt exp. [SP=117 Cap=188m]
NIOX (NIOX) guides H1-June rev up 22% and adj EBITDA c. £6.2m (£3.2m). Guides FY ahead of mgmt exp. [SP=64.5 Cap=273m]
Pelatro (PTRO) a key customer, owing $550k, will miss agreed payment deadline of July. Review (why does this need a review?) finds 'unusual' delays in payments from 4 customers, tot c.$1.1m. Expects a positive resolution from talks. Cash at hand $0.7m and c.$2.6m coming in by Sept. Exploring financing and funding options in case customers don't pay. [SP=7.68 Cap=4m]
Zotefoams (ZTF) joint development agreement with a world-leading packer for ReZorce beverage cartons. [SP=338 Cap=156m]
IXICO (IXI) $1.7m 4 yr contract. [SP=18.75 Cap=9m]
In line: APH, ART, CPP, BMY, VCAP, JDG, MIRI, DX.
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 20-Jul-23
The Big Weep
AMTE Power (AMTE) will go into administration if no funds forthcoming within a few days. [SP=8.44 Cap=3m]
Pittards (PTD) a trade Investor will subscribe for £1m max shares at 4p contingent on co raising a minimum of £1.16m and new banking facilities. Share remain suspended. Will probably go bust if investments don't happen. [SP=5.47 Cap=2m]
Fuller, Smith & Turner (FSTA) AGM stmt - recent 15 weeks rev up 17%. CEO 'very pleased'. In line? 1m share buyback. [SP=572 Cap=225m]
KRM22 (KRM) guides H1-June rev £2.4m (£1.9m), ARR £5m (£4.1m). In line? [SP=45 Cap=16m]
Litigation Capital Management (LIT) a funded party has succeeded in its claim. May be appealed. LIT investment A$5.7m; cannot calculate overall return until case concludes. [SP=91 Cap=108m]
Netcall (NET) guides FY-June rev up 21% with underlying total annual contract value also up 21%. Net funds £24.8m. 5 yr contract renewal worth $20m tot. [SP=112.5 Cap=180m]
Brand Architekts (BAR) guides FY-June up 41% but only c. 7% LFL "due to strong international sales offset by challenging trading conditions in UK channels". H2 op loss down. In line? "We are confident that our brand development and brand reach strategic pillars will help us achieve our profit goals." Settles claim by its Mr Haircare JV partner for £200k + legal costs £225k. Will buy JV partner's 55% shareholding. [SP=29.75 Cap=8m]
Arecor Therapeutics (AREC) biz and drug dev update. [SP=200 Cap=61m]
Portmeirion (PMP) guides H1-June rev down 3%. US and Canada weakness continues with rev down 14% but "end customer demand remains robust". Elsewhere in line. [SP=399 Cap=56m]
Iofina (IOF) guides H1 production in line. IO#9 needed additional equipment and installation costs compared to other plants. Total expenditure including reused equipment $5.5m. [SP=31.75 Cap=61m]
Fonix Mobile (FNX) guides FY-June rev and profit marginally ahead of market expectations. [SP=205 Cap=204m]
AEW UK REIT (AEWU) NAV 107.03p/sh cf 105.48p in March. [SP=98.2 Cap=156m]
Acuity RM (ACRM) wins 3 yr contract worth £388k for software platform STREAM. [SP=6.66 Cap=8m]
In line: VP., KIE, PDG, ALU
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
The Big Weep
AMTE Power (AMTE) will go into administration if no funds forthcoming within a few days. [SP=8.44 Cap=3m]
Pittards (PTD) a trade Investor will subscribe for £1m max shares at 4p contingent on co raising a minimum of £1.16m and new banking facilities. Share remain suspended. Will probably go bust if investments don't happen. [SP=5.47 Cap=2m]
Fuller, Smith & Turner (FSTA) AGM stmt - recent 15 weeks rev up 17%. CEO 'very pleased'. In line? 1m share buyback. [SP=572 Cap=225m]
KRM22 (KRM) guides H1-June rev £2.4m (£1.9m), ARR £5m (£4.1m). In line? [SP=45 Cap=16m]
Litigation Capital Management (LIT) a funded party has succeeded in its claim. May be appealed. LIT investment A$5.7m; cannot calculate overall return until case concludes. [SP=91 Cap=108m]
Netcall (NET) guides FY-June rev up 21% with underlying total annual contract value also up 21%. Net funds £24.8m. 5 yr contract renewal worth $20m tot. [SP=112.5 Cap=180m]
Brand Architekts (BAR) guides FY-June up 41% but only c. 7% LFL "due to strong international sales offset by challenging trading conditions in UK channels". H2 op loss down. In line? "We are confident that our brand development and brand reach strategic pillars will help us achieve our profit goals." Settles claim by its Mr Haircare JV partner for £200k + legal costs £225k. Will buy JV partner's 55% shareholding. [SP=29.75 Cap=8m]
Arecor Therapeutics (AREC) biz and drug dev update. [SP=200 Cap=61m]
Portmeirion (PMP) guides H1-June rev down 3%. US and Canada weakness continues with rev down 14% but "end customer demand remains robust". Elsewhere in line. [SP=399 Cap=56m]
Iofina (IOF) guides H1 production in line. IO#9 needed additional equipment and installation costs compared to other plants. Total expenditure including reused equipment $5.5m. [SP=31.75 Cap=61m]
Fonix Mobile (FNX) guides FY-June rev and profit marginally ahead of market expectations. [SP=205 Cap=204m]
AEW UK REIT (AEWU) NAV 107.03p/sh cf 105.48p in March. [SP=98.2 Cap=156m]
Acuity RM (ACRM) wins 3 yr contract worth £388k for software platform STREAM. [SP=6.66 Cap=8m]
In line: VP., KIE, PDG, ALU
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 21-Jul-23
Rapid RNS reduction
Filtronic (FTC) €3.7 million payload development project from the European Space Agency. Included in FY24 F/C. Final hardware deliverable by Mar 2025. [SP=15.31 Cap=33m]
Renalytix (RENX) distribution agreement makes kidneyintelX.dkd available in Middle East. [SP=122.23 Cap=155m]
DP Poland (DPP) guides H1 LFL up 18%. Order counts up 11%. "We expect performance to continue improving and remain optimistic about the outlook." [SP=7.7 Cap=55m]
Samuel Heath (HSM) FY-Mar rev up 5% but pretax £0.93m (£1.47m). "iven the uncertainties at the half year, the overall result was better than we feared might be the case, also taking into account that the previous year saw exceptional outperformance at the profit level due to what we highlighted at the time to be unsustainably low cost levels....Order book held up reasonably well during the year, but sales were held back by production difficulties caused by machinery breakdowns and labour shortages." Current trading -some weakness. [SP=462.5 Cap=12m]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Rapid RNS reduction
Filtronic (FTC) €3.7 million payload development project from the European Space Agency. Included in FY24 F/C. Final hardware deliverable by Mar 2025. [SP=15.31 Cap=33m]
Renalytix (RENX) distribution agreement makes kidneyintelX.dkd available in Middle East. [SP=122.23 Cap=155m]
DP Poland (DPP) guides H1 LFL up 18%. Order counts up 11%. "We expect performance to continue improving and remain optimistic about the outlook." [SP=7.7 Cap=55m]
Samuel Heath (HSM) FY-Mar rev up 5% but pretax £0.93m (£1.47m). "iven the uncertainties at the half year, the overall result was better than we feared might be the case, also taking into account that the previous year saw exceptional outperformance at the profit level due to what we highlighted at the time to be unsustainably low cost levels....Order book held up reasonably well during the year, but sales were held back by production difficulties caused by machinery breakdowns and labour shortages." Current trading -some weakness. [SP=462.5 Cap=12m]
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 24-Jul-23
A cluster of news bomblets
Arcontech (ARC) guides FY-June rev in line and adj pretax ahead of market expectations by c.49%. Cites one-off savings of lower than anticipated staff related costs arising from lower variable costs and delayed hires. [SP=62.55 Cap=9m]
Inland Homes (INL) new CEO, Jolyon Harrison. Agrees terms to buy his 51% owned NorthCountry for £4m in paper. Subject to shareholder vote and restoration to trading. [SP=8.5 Cap=23m]
CentralNic (CNIC) guides H1 net rev up 11% and adj EBITDA up 15%+. Expects FY at least in line with market expectations. [SP=127.4 Cap=358m]
Trackwise Designs (TWD) hoists For Sale flag. [SP=NA Cap=NA]
Beeks Financial Cloud (BKS) wins contracts worth of $4m. No period stated. [SP=104.86 Cap=69m]
SIMEC Atlantis Energy (SAE) receives next payment, of £4m, for BESS project at Uskmouth. Expects to publish its late AR this month. [SP=0.95 Cap=7m]
Intelligent Ultrasound (IUG) guides H1-June rev up 3% but 25% excluding one-off last yr. "Cash utilisation in H2 is expected to be materially lower and the Group remains on target to reach profitability with its current cash." [SP=8.95 Cap=29m]
Haydale Graphene Industries (HAYD) £350k one yr contract to develop graphene ink-based low-power radiator heaters. [SP=1.13 Cap=9m]
Quantum Blockchain Technologies (QBT) applies for UK patent for Bitcoin mining technique. [SP=1.5 Cap=17m]
PayPoint (PAY) guides FY-Mar adj pretax at the top end of the range of market expectations. [SP=447.5 Cap=325m]
Kromek (KMK) FY-Apr rev up 44%. Adj EBITDA loss £1m (£1.2m), significantly ahead of market expectations. Outlook - expects substantial increase in revenue and positive adj EBITDA. [SP=5 Cap=30m]
In line: CABP, SRC, SOM, SAG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
A cluster of news bomblets
Arcontech (ARC) guides FY-June rev in line and adj pretax ahead of market expectations by c.49%. Cites one-off savings of lower than anticipated staff related costs arising from lower variable costs and delayed hires. [SP=62.55 Cap=9m]
Inland Homes (INL) new CEO, Jolyon Harrison. Agrees terms to buy his 51% owned NorthCountry for £4m in paper. Subject to shareholder vote and restoration to trading. [SP=8.5 Cap=23m]
CentralNic (CNIC) guides H1 net rev up 11% and adj EBITDA up 15%+. Expects FY at least in line with market expectations. [SP=127.4 Cap=358m]
Trackwise Designs (TWD) hoists For Sale flag. [SP=NA Cap=NA]
Beeks Financial Cloud (BKS) wins contracts worth of $4m. No period stated. [SP=104.86 Cap=69m]
SIMEC Atlantis Energy (SAE) receives next payment, of £4m, for BESS project at Uskmouth. Expects to publish its late AR this month. [SP=0.95 Cap=7m]
Intelligent Ultrasound (IUG) guides H1-June rev up 3% but 25% excluding one-off last yr. "Cash utilisation in H2 is expected to be materially lower and the Group remains on target to reach profitability with its current cash." [SP=8.95 Cap=29m]
Haydale Graphene Industries (HAYD) £350k one yr contract to develop graphene ink-based low-power radiator heaters. [SP=1.13 Cap=9m]
Quantum Blockchain Technologies (QBT) applies for UK patent for Bitcoin mining technique. [SP=1.5 Cap=17m]
PayPoint (PAY) guides FY-Mar adj pretax at the top end of the range of market expectations. [SP=447.5 Cap=325m]
Kromek (KMK) FY-Apr rev up 44%. Adj EBITDA loss £1m (£1.2m), significantly ahead of market expectations. Outlook - expects substantial increase in revenue and positive adj EBITDA. [SP=5 Cap=30m]
In line: CABP, SRC, SOM, SAG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 25-Jul-23
Pier pressure
Brighton Pier (PIER) warns H1-June rev only £16.2m and post-tax below market expectations after weak Q2. July also weak - blames weather, train strikes. [SP=58.92 Cap=21m]
ITM Power (ITM) FY audited results delayed to 17 Au. Blames auditors. Confirms guidance. [SP=98.58 Cap=607m]
Trackwise Designs (TWD) terminates contract with UK EV OEM (see June 30) due to failure to honour contract terms. [SP=NA Cap=NA]
Proton Motor Power Systems (PPS) order for a standalone fuel cell system based on a 50kW container solution for deluvery in FY24. No £££. [SP=8.5 Cap=132m]
FireAngel Safety Technology (FA.) brief flames of hope extinguished as it warns H1 rev down 17% and pretax loss £3.7m, £2m worse (including £1.1m losses on hedging contracts). Blames continued weak trading. [SP=4.32 Cap=13m]
Aeorema Communications (AEO) guides FY-June rev up 62% and pretax £950k+ (£844k). In line? Outlook: strong momentum. [SP=78.5 Cap=7m]
hVIVO (HVO) £13.1m contract to develop an influenza B virus challenge model. Rev recognised throughout 2023 and 2024. [SP=15.46 Cap=105m]
Yü (YU.) guides FY-Dec rev above exp and significantly increased EBITDA margin. Co now targets £500m revenue with 5%+ sustainable EBITDA margin in the short to medium term. [SP=750 Cap=125m]
Northcoders (CODE) £4.5m contract. Guides FY-Dec comfortably in line with management expectations. [SP=218 Cap=17m]
Actual Experience (ACT) wins second order (£135k) for its Digital Workplace Management Platform [SP=0.5 Cap=1m]
Tristel (TSTL) guides FY-June ahead of both analyst expectations and co's growth targets. [SP=354.5 Cap=168m]
Hargreaves Services (HSP) independent valuation of renewable energy land assets of £21.6m-23.1m. [SP=448.91 Cap=146m]
Fadel Partners (FADL) guides FY-Dec rev in line, H2 weighted. Profit not mentioned. [SP=147 Cap=30m]
In line: RCH, SAAS, DXRX, PEBB, ECEL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Pier pressure
Brighton Pier (PIER) warns H1-June rev only £16.2m and post-tax below market expectations after weak Q2. July also weak - blames weather, train strikes. [SP=58.92 Cap=21m]
ITM Power (ITM) FY audited results delayed to 17 Au. Blames auditors. Confirms guidance. [SP=98.58 Cap=607m]
Trackwise Designs (TWD) terminates contract with UK EV OEM (see June 30) due to failure to honour contract terms. [SP=NA Cap=NA]
Proton Motor Power Systems (PPS) order for a standalone fuel cell system based on a 50kW container solution for deluvery in FY24. No £££. [SP=8.5 Cap=132m]
FireAngel Safety Technology (FA.) brief flames of hope extinguished as it warns H1 rev down 17% and pretax loss £3.7m, £2m worse (including £1.1m losses on hedging contracts). Blames continued weak trading. [SP=4.32 Cap=13m]
Aeorema Communications (AEO) guides FY-June rev up 62% and pretax £950k+ (£844k). In line? Outlook: strong momentum. [SP=78.5 Cap=7m]
hVIVO (HVO) £13.1m contract to develop an influenza B virus challenge model. Rev recognised throughout 2023 and 2024. [SP=15.46 Cap=105m]
Yü (YU.) guides FY-Dec rev above exp and significantly increased EBITDA margin. Co now targets £500m revenue with 5%+ sustainable EBITDA margin in the short to medium term. [SP=750 Cap=125m]
Northcoders (CODE) £4.5m contract. Guides FY-Dec comfortably in line with management expectations. [SP=218 Cap=17m]
Actual Experience (ACT) wins second order (£135k) for its Digital Workplace Management Platform [SP=0.5 Cap=1m]
Tristel (TSTL) guides FY-June ahead of both analyst expectations and co's growth targets. [SP=354.5 Cap=168m]
Hargreaves Services (HSP) independent valuation of renewable energy land assets of £21.6m-23.1m. [SP=448.91 Cap=146m]
Fadel Partners (FADL) guides FY-Dec rev in line, H2 weighted. Profit not mentioned. [SP=147 Cap=30m]
In line: RCH, SAAS, DXRX, PEBB, ECEL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 26-Jul-23
Fat RNS sandwich with sour toppings.
Velocity Composites (VEL) $100m, five-year Work Package Agreement (see Dec RNS) warns FY23 only £15-17m and EBITDA loss £1.2-1.6m due to delay in $100m contract (see Dec RNS). Cuts expected rev in FY23 to £2.2m from £5m. "Once the programme transfer from the Customer to Velocity is completed, revenues under the Agreement will be more predictable." [SP=51.2 Cap=19m]
Learning Technologies (LTG) warns FY-H1 organic rev flat. Rev-cont up 2%. Blames "lower than expected level of transactional and project-based work due to the lengthening of sales cycles, particularly for our financial services and technology clients". Guides FY-Dc rev £550-570m and edj EBIT £98-103m. F/C were £609.2m and £109.4m. [SP=84.82 Cap=671m]
Smarttech247 (S247) $3m 3 year order for security intelligence technology. [SP=31 Cap=38m]
Palace Capital (PCA) AGM stmt - proforma EPRA NTA is 304p. [SP=237 Cap=99m]
Wilmington (WIL) guides FY-June rev organic up 9%. Adj pretax £24.3m ahead of F/C £22.8m. [SP=250 Cap=220m]
Yourgene Health (YGEN) five-year contract extension with Illumina. No £££. [SP=0.5 Cap=16m]
Marston's (MARS) last 42 rev LFL up 11%. In line? [SP=31.9 Cap=202m]
Saietta (SED) Letter of Assignment for a third vehicle line with its existing Indian client. Expects 60k units over 5 yrs. [SP=35.4 Cap=36m]
Oakley Capital Investments (OCI) NAV 663p/sh. [SP=447.67 Cap=790m]
Motorpoint (MOTR) AGM stmt - mixed. "We are able to maintain a lower headcount as we conserve cash and return to profitability, whilst ensuring we are ready to invest for growth as more favourable market conditions return. The Group continues to be confident it will emerge in a normalised market as a leaner and more valuable business ready to seize a significant opportunity." [SP=102 Cap=92m]
Graft Polymer UK (GPL) distribution agreement with leading US veterinary products company Inter-Technologies. "The agreement is a major step forward in expanding the penetration of the Company's GraftBio products." [SP=1.7 Cap=2m]
SEEEN (SEEN) AGM stmt - commercial readiness of CreatorSuite 2.0. [SP=2.5 Cap=2m]
In line: RBG, TIA, MAB1, LBG, HVO, EKF, GHE, NXR, BIOM, IQE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Fat RNS sandwich with sour toppings.
Velocity Composites (VEL) $100m, five-year Work Package Agreement (see Dec RNS) warns FY23 only £15-17m and EBITDA loss £1.2-1.6m due to delay in $100m contract (see Dec RNS). Cuts expected rev in FY23 to £2.2m from £5m. "Once the programme transfer from the Customer to Velocity is completed, revenues under the Agreement will be more predictable." [SP=51.2 Cap=19m]
Learning Technologies (LTG) warns FY-H1 organic rev flat. Rev-cont up 2%. Blames "lower than expected level of transactional and project-based work due to the lengthening of sales cycles, particularly for our financial services and technology clients". Guides FY-Dc rev £550-570m and edj EBIT £98-103m. F/C were £609.2m and £109.4m. [SP=84.82 Cap=671m]
Smarttech247 (S247) $3m 3 year order for security intelligence technology. [SP=31 Cap=38m]
Palace Capital (PCA) AGM stmt - proforma EPRA NTA is 304p. [SP=237 Cap=99m]
Wilmington (WIL) guides FY-June rev organic up 9%. Adj pretax £24.3m ahead of F/C £22.8m. [SP=250 Cap=220m]
Yourgene Health (YGEN) five-year contract extension with Illumina. No £££. [SP=0.5 Cap=16m]
Marston's (MARS) last 42 rev LFL up 11%. In line? [SP=31.9 Cap=202m]
Saietta (SED) Letter of Assignment for a third vehicle line with its existing Indian client. Expects 60k units over 5 yrs. [SP=35.4 Cap=36m]
Oakley Capital Investments (OCI) NAV 663p/sh. [SP=447.67 Cap=790m]
Motorpoint (MOTR) AGM stmt - mixed. "We are able to maintain a lower headcount as we conserve cash and return to profitability, whilst ensuring we are ready to invest for growth as more favourable market conditions return. The Group continues to be confident it will emerge in a normalised market as a leaner and more valuable business ready to seize a significant opportunity." [SP=102 Cap=92m]
Graft Polymer UK (GPL) distribution agreement with leading US veterinary products company Inter-Technologies. "The agreement is a major step forward in expanding the penetration of the Company's GraftBio products." [SP=1.7 Cap=2m]
SEEEN (SEEN) AGM stmt - commercial readiness of CreatorSuite 2.0. [SP=2.5 Cap=2m]
In line: RBG, TIA, MAB1, LBG, HVO, EKF, GHE, NXR, BIOM, IQE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 27-Jul-23
Well, here's another fine mess I've gotten myself into!
RBG Holdings (RBGP) warns FY-Dec EBITDA only £10-12m. Legal Services broadly in line but Convex Capital transactions taking longer to complete as a consequence of the current economic environment. Writes down all funded litigations to nil from £13.3m. 13 were done by Legal Services, not LionFish. Div suspended. Astonishing work by sacked CEO and team. [SP=25.4 Cap=24m]
Mission (TMG) warns FY-Dec ikely to be at the lower end of mgmt expectations, with pretax still above FY22. Blames "hallenges in the US technology sector and the reduced level of activity in this market in 2023 has impacted margin mix, particularly in comparison to 2022". [SP=43.25 Cap=39m]
eEnergy (EAAS) guides 12 months to June rev up 50% and adj pretax up 34%. Outlook "confident in the trading outlook for the remainder of FY23 [18 mth FY]". [SP=5.5 Cap=19m]
Lookers (LOOK) inc rec offer of 130p, from 120p. [SP=95 Cap=363m]
Safestyle (SFE) warns FY-Jan24 materially below market expectations due to weak demand. H1 rev down 5%, in line. Industry data for last 3 month shows installations down c.12%. Conditions have worsened over the last 5 weeks into July. [SP=18.96 Cap=26m]
Litigation Capital Management (LIT) update following yesterday's UK Supreme Court Ruling on litigation funding. "The decision will have very limited or no impact on LCM's portfolios of dispute investments in terms of future value...[in fact] will have a potential positive impact on our future market share, given the lack of diversity in a number of our key competitors." [SP=72.6 Cap=87m]
Dotdigital (DOTD) guides FY-June rev up 10%, lightly ahead of market expectations. Pretax in line.Outlook confident. [SP=88 Cap=263m]
Harworth (HWG) EPRA NDV at 30 June broadly in line with 31 Dec. [SP=119.5 Cap=382m]
Empresaria (EMR) warns FY adj pretax materially lower than market expectations. Blames "difficult market conditions have been experienced across the Group, particularly in the US. The greatest net fee income impact has been on permanent recruitment which was down 24% year-on-year with temporary and contract down 8%." [SP=51 Cap=26m]
DP Eurasia (DPEU) guides FY-Dec LFL sales (inflation adjusted) growth in the low teens, better than previously expected high single digits. [SP=46.91 Cap=69m]
Headlam (HEAD) wanrs FY-Dec adj pretax significantly below market expectations. H1 rev up 2.5% despite residential own nearly 7%. U/L pretax £6m (£17m) partly due to "strategic related investmen". "Recent residential trading volumes are weaker than expectations, with recovery now expected to take place over a more prolonged period." [SP=243 Cap=196m]
Novacyt (NCYT) guides H1-June rev down 80% to £3.3m. Even non-covid rev down. "Well positioned for diversified organic and non-organic growth." Yes, from FA. [SP=63.2 Cap=54m]
Hansard Global (HSD) guides FY-June ew business down 29%. Blames "general hesitancy by clients to commit to long-term savings products". In line? "We are confident that our new product pipeline will lead to increased sales and long term growth in the business." [SP=46.6 Cap=64m]
In line: YGEN, XLM, BGO, ANCR, ELCO, FNTL, GMR, VLX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Well, here's another fine mess I've gotten myself into!
RBG Holdings (RBGP) warns FY-Dec EBITDA only £10-12m. Legal Services broadly in line but Convex Capital transactions taking longer to complete as a consequence of the current economic environment. Writes down all funded litigations to nil from £13.3m. 13 were done by Legal Services, not LionFish. Div suspended. Astonishing work by sacked CEO and team. [SP=25.4 Cap=24m]
Mission (TMG) warns FY-Dec ikely to be at the lower end of mgmt expectations, with pretax still above FY22. Blames "hallenges in the US technology sector and the reduced level of activity in this market in 2023 has impacted margin mix, particularly in comparison to 2022". [SP=43.25 Cap=39m]
eEnergy (EAAS) guides 12 months to June rev up 50% and adj pretax up 34%. Outlook "confident in the trading outlook for the remainder of FY23 [18 mth FY]". [SP=5.5 Cap=19m]
Lookers (LOOK) inc rec offer of 130p, from 120p. [SP=95 Cap=363m]
Safestyle (SFE) warns FY-Jan24 materially below market expectations due to weak demand. H1 rev down 5%, in line. Industry data for last 3 month shows installations down c.12%. Conditions have worsened over the last 5 weeks into July. [SP=18.96 Cap=26m]
Litigation Capital Management (LIT) update following yesterday's UK Supreme Court Ruling on litigation funding. "The decision will have very limited or no impact on LCM's portfolios of dispute investments in terms of future value...[in fact] will have a potential positive impact on our future market share, given the lack of diversity in a number of our key competitors." [SP=72.6 Cap=87m]
Dotdigital (DOTD) guides FY-June rev up 10%, lightly ahead of market expectations. Pretax in line.Outlook confident. [SP=88 Cap=263m]
Harworth (HWG) EPRA NDV at 30 June broadly in line with 31 Dec. [SP=119.5 Cap=382m]
Empresaria (EMR) warns FY adj pretax materially lower than market expectations. Blames "difficult market conditions have been experienced across the Group, particularly in the US. The greatest net fee income impact has been on permanent recruitment which was down 24% year-on-year with temporary and contract down 8%." [SP=51 Cap=26m]
DP Eurasia (DPEU) guides FY-Dec LFL sales (inflation adjusted) growth in the low teens, better than previously expected high single digits. [SP=46.91 Cap=69m]
Headlam (HEAD) wanrs FY-Dec adj pretax significantly below market expectations. H1 rev up 2.5% despite residential own nearly 7%. U/L pretax £6m (£17m) partly due to "strategic related investmen". "Recent residential trading volumes are weaker than expectations, with recovery now expected to take place over a more prolonged period." [SP=243 Cap=196m]
Novacyt (NCYT) guides H1-June rev down 80% to £3.3m. Even non-covid rev down. "Well positioned for diversified organic and non-organic growth." Yes, from FA. [SP=63.2 Cap=54m]
Hansard Global (HSD) guides FY-June ew business down 29%. Blames "general hesitancy by clients to commit to long-term savings products". In line? "We are confident that our new product pipeline will lead to increased sales and long term growth in the business." [SP=46.6 Cap=64m]
In line: YGEN, XLM, BGO, ANCR, ELCO, FNTL, GMR, VLX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 28-Jul-23
Broker broke
W.H. Ireland (WHI) £5m placing at 3p, an 87% discount, to prevent a solvent wind down. Co is c.£1.9m below the current FCA regulatory capital requirement. CM transactional activity poor. Expects co to be loss making until at least Nov. [SP=21 Cap=14m]
AFC Energy (AFC) proposed launch of a dedicated hydrogen powered generator plant hire business in JV with Speedy Hire. [SP=14.68 Cap=110m]
Cineworld (CINE) administration of group (as expected) on July 31, shares suspended day after. When will we seen another blockbuster short like this? [SP=0.38 Cap=5m]
Greencore (GNC) to sell Trilby Trading, one of Ireland's leading importers and distributors of vegetable oils and fats for the food processing, for €9.8m. Trilby made pretax of €2.9m. "Trilby is a great business with attractive assets and a fantastic team. However, given our strategic focus on the UK convenience food market, it is no longer a core part of Greencore's plans." Why did co sell it for 3.4x pretax? [SP=87.1 Cap=425m]
In line: SPEC, PAY
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Broker broke
W.H. Ireland (WHI) £5m placing at 3p, an 87% discount, to prevent a solvent wind down. Co is c.£1.9m below the current FCA regulatory capital requirement. CM transactional activity poor. Expects co to be loss making until at least Nov. [SP=21 Cap=14m]
AFC Energy (AFC) proposed launch of a dedicated hydrogen powered generator plant hire business in JV with Speedy Hire. [SP=14.68 Cap=110m]
Cineworld (CINE) administration of group (as expected) on July 31, shares suspended day after. When will we seen another blockbuster short like this? [SP=0.38 Cap=5m]
Greencore (GNC) to sell Trilby Trading, one of Ireland's leading importers and distributors of vegetable oils and fats for the food processing, for €9.8m. Trilby made pretax of €2.9m. "Trilby is a great business with attractive assets and a fantastic team. However, given our strategic focus on the UK convenience food market, it is no longer a core part of Greencore's plans." Why did co sell it for 3.4x pretax? [SP=87.1 Cap=425m]
In line: SPEC, PAY
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
-
MrContrarian
- Lemon Quarter
- Posts: 1778
- Joined: November 4th, 2016, 2:45 pm
- Has thanked: 43 times
- Been thanked: 1611 times
Re: MrC's Smallcap Sweeps for Jul 2023
Smallcap Sweep. 31-Jul-23
Ferrying news across the Styx
Aptamer (APTA) £3.6m placing at 1p, a disgraceful 79% discount, to keep the lights on. SP was 95 a yr ago. Cost cuts. 4 directors resign. Ends Formal Sale process. [SP=4.56 Cap=3m]
Marshalls (MSLH) warns FY-Dec below exp. Blames "sustained high levels of inflation, increasing interest rates and weak consumer confidence". [SP=276.2 Cap=696m]
EQTEC (EQT) successful completion of steam-oxygen gasification tests for Biogaz Gardanne project. [SP=0.16 Cap=18m]
Flowtech Fluidpower (FLO) warns FY-Dec significantly behind expectations of rev c.£119.4m and pretax c.£8.8m. Flowtech division H1 rev down 6%. "Specific actions are in flight to address commercial and operational shortfalls adversely impacting performance, some of which require targeted new capital investment and some to address legacy issues." [SP=117 Cap=71m]
Harland & Wolff (HARL) get Notice to Proceed (= Letter of Intent) for the mid-life upgrade and dry docking of a large vessel worth £60-70m in early 2024. [SP=11.58 Cap=20m]
Glantus (GLAN) guides H1-June rev ahead of mgmt exp. [SP=18.25 Cap=10m]
AIQ (AIQ) extends convertible facility by 1 yr, to Jan 2025. [SP=10.48 Cap=8m]
Chrysalis Investments (CHRY) June NAV 136.86p/sh, up 5.3% since Mar. [SP=74 Cap=438m]
Real Estate Investors (RLE) trading update. Sounds OK. Snippet: "We have experienced slow occupier decision making since the year end, however, due to our healthy pipeline of lettings, and with our further scheduled sales, we anticipate improved contracted rental income, WAULT and occupancy." [SP=29.82 Cap=51m]
Polarean Imaging (POLX) University of Missouri Health Care to begin clinical imaging with XENOVIEW. [SP=21.32 Cap=45m]
In line: GTLY, VLG, SCE, ING, EPWN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Ferrying news across the Styx
Aptamer (APTA) £3.6m placing at 1p, a disgraceful 79% discount, to keep the lights on. SP was 95 a yr ago. Cost cuts. 4 directors resign. Ends Formal Sale process. [SP=4.56 Cap=3m]
Marshalls (MSLH) warns FY-Dec below exp. Blames "sustained high levels of inflation, increasing interest rates and weak consumer confidence". [SP=276.2 Cap=696m]
EQTEC (EQT) successful completion of steam-oxygen gasification tests for Biogaz Gardanne project. [SP=0.16 Cap=18m]
Flowtech Fluidpower (FLO) warns FY-Dec significantly behind expectations of rev c.£119.4m and pretax c.£8.8m. Flowtech division H1 rev down 6%. "Specific actions are in flight to address commercial and operational shortfalls adversely impacting performance, some of which require targeted new capital investment and some to address legacy issues." [SP=117 Cap=71m]
Harland & Wolff (HARL) get Notice to Proceed (= Letter of Intent) for the mid-life upgrade and dry docking of a large vessel worth £60-70m in early 2024. [SP=11.58 Cap=20m]
Glantus (GLAN) guides H1-June rev ahead of mgmt exp. [SP=18.25 Cap=10m]
AIQ (AIQ) extends convertible facility by 1 yr, to Jan 2025. [SP=10.48 Cap=8m]
Chrysalis Investments (CHRY) June NAV 136.86p/sh, up 5.3% since Mar. [SP=74 Cap=438m]
Real Estate Investors (RLE) trading update. Sounds OK. Snippet: "We have experienced slow occupier decision making since the year end, however, due to our healthy pipeline of lettings, and with our further scheduled sales, we anticipate improved contracted rental income, WAULT and occupancy." [SP=29.82 Cap=51m]
Polarean Imaging (POLX) University of Missouri Health Care to begin clinical imaging with XENOVIEW. [SP=21.32 Cap=45m]
In line: GTLY, VLG, SCE, ING, EPWN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.
RNSs
http://www.investegate.co.uk
@MrContrarian
Return to “Stocks and Share Dealing Discussions”
Who is online
Users browsing this forum: No registered users and 37 guests